Entheon Biomedical Corp. (CSE:ENBI)
Canada flag Canada · Delayed Price · Currency is CAD
0.0900
0.00 (0.00%)
Dec 5, 2025, 9:30 AM EST

Entheon Biomedical Ratios and Metrics

Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2019
Market Capitalization
11123231
Upgrade
Market Cap Growth
111.09%109.89%-66.67%-94.44%3.86%-
Upgrade
Enterprise Value
11022829
Upgrade
Last Close Price
0.090.140.100.305.407.60
Upgrade
PS Ratio
--2.369.35--
Upgrade
PB Ratio
3.218.531.872.883.528.20
Upgrade
P/TBV Ratio
3.218.531.872.8810.138.20
Upgrade
EV/Sales Ratio
--0.848.04--
Upgrade
Asset Turnover
--0.430.04--
Upgrade
Quick Ratio
21.163.544.114.672.244.00
Upgrade
Current Ratio
21.844.534.644.813.466.05
Upgrade
Return on Equity (ROE)
-110.91%-137.90%-64.49%-42.66%-125.03%-231.39%
Upgrade
Return on Assets (ROA)
-67.20%-70.93%-33.41%-41.88%-71.06%-44.49%
Upgrade
Return on Capital (ROIC)
-71.40%-90.19%-42.03%-46.57%-80.25%-54.11%
Upgrade
Return on Capital Employed (ROCE)
-90.80%-228.90%-99.10%-585.80%-90.80%-43.80%
Upgrade
Earnings Yield
-27.48%-25.63%-50.77%-480.67%-27.87%-14.27%
Upgrade
FCF Yield
--28.68%-60.91%-110.26%-16.72%-9.27%
Upgrade
Buyback Yield / Dilution
-73.57%-30.96%--8.85%-97.83%-543.78%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.